Pomegranates and Alzheimer’s: A Promising Discovery
A substance naturally occurring in pomegranates can improve memory and the treatment of Alzheimer’s disease, a new study concluded. The findings suggest that a compound called urolithin A, found in pomegranates, could be a potential game-changer in the fight against Alzheimer’s.
Forgetfulness, difficulty finding words, and confusion about time and place are some of the most common symptoms of Alzheimer’s disease. Researchers at the University of Copenhagen have discovered that an ordinary fruit might help alleviate these symptoms. Their study on mice with Alzheimer’s shows that urolithin A can “alleviate memory problems and other consequences of dementia,” according to Vilhelm Bohr, Affiliate Professor at the University’s Department of Cellular and Molecular Medicine.
“This is good news for patients with dementia,” Bohr stated. “Even though the study was conducted on mouse models, the prospects are positive. So far, research has shown promising results for the substance.” Clinical trials on humans are currently being planned, which could pave the way for new treatments for Alzheimer’s patients.
Substance Helps Improve Brain Function
The researchers previously discovered that a specific molecule, nicotinamide riboside (NAD supplement), plays a key role in neurodegenerative diseases such as Alzheimer’s and Parkinson’s. NAD supplements actively help remove damaged mitochondria from the brain, a process known as mitophagy. “Many patients with neurodegenerative diseases experience mitochondrial dysfunction, also known as mitophagy. This means that the brain has difficulties removing weak mitochondria, which thus accumulate and affect brain function,” explained Bohr. “If you are able to stimulate the mitophagy process, removing weak mitochondria, you will see some very positive results.”
The new study shows that urolithin A removes weak mitochondria from the brain just as effectively as NAD supplements. Mitochondria, often referred to as the powerhouses of cells, are essential for energy production and cellular health. Dysfunctional mitochondria can lead to impaired brain function, which is a hallmark of Alzheimer’s and other neurodegenerative diseases. By promoting the removal of these damaged mitochondria, urolithin A could potentially improve brain function in Alzheimer’s patients.
Dosage and Further Research
While the study’s findings are promising, researchers still don’t know how much urolithin A is needed for humans to improve memory and alleviate symptoms. “We still cannot say anything conclusive about the dosage, but I imagine that it is more than a pomegranate a day,” said Bohr. He also hopes the substance can be used for preventive purposes with no significant side effects.
“Several studies so far show that there are no serious side effects of NAD supplementation. Our knowledge of urolithin A is more limited, but clinical trials with urolithin A have been effective in muscular disease,” Bohr noted. This opens up the possibility of using urolithin A not only as a treatment but also as a preventive measure against Alzheimer’s.
Publication and Future Directions
The study, titled Urolithin A improves Alzheimer’s disease cognition and restores mitophagy and lysosomal functions, has been published in Alzheimer’s and Dementia. The publication of these findings marks a significant step forward in Alzheimer’s research, offering hope for new treatment options.
As clinical trials on humans are being planned, researchers are optimistic about the potential applications of urolithin A. If proven effective in humans, this natural compound could be integrated into treatment plans for Alzheimer’s patients, potentially improving their quality of life.
The discovery of urolithin A’s benefits highlights the importance of exploring natural compounds and their potential health benefits. As researchers continue to investigate the mechanisms behind urolithin A’s effects, there is hope that this substance could lead to breakthroughs in the treatment and prevention of Alzheimer’s disease.